In the Annex to Framework Decision 2004/757/JHA, the following points 20 and 21 are added:
‘20. 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-MMC) [Commission Delegated Directive (EU) 2022/1326 of 18 March 2022 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of new psychoactive substances in the definition of ‘drug’ (OJ L 200, xx.xx.2022, p. 148).’].
21.
1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-CMC).